Clinical Research Directory
Browse clinical research sites, groups, and studies.
Digitally Enhanced Smoking Cessation for High Risk Smokers
Sponsor: Dana-Farber Cancer Institute
Summary
This is a research study, is testing a program to improve lung health through smoking cessation and providing education around lung screening. In this research study involves Studying the Enhanced Smoking Cessation Approaches to Promote Empowerment (ESCAPE) program compared to usual care. The ESCAPE program was developed help women with HIV quit smoking. Women in the ESCAPE program quit smoking and stayed quit for longer (up to 3 months). For this study, investigators have added a lung screening to the ESCAPE program and want to test if this will improve lung health through increasing quit rates and lung screening. .
Official title: A Digitally-enhanced Smoking Cessation Intervention for High-risk Smokers: Phase II
Key Details
Gender
All
Age Range
55 Years - 77 Years
Study Type
INTERVENTIONAL
Enrollment
153
Start Date
2021-02-01
Completion Date
2026-12-01
Last Updated
2025-12-19
Healthy Volunteers
Yes
Interventions
Escape
The ESCAPE intervention consists of five components:1) behavioral counseling, 2) the use of NRT, 3) digital SNC 4) decision aid about LDCT screening, and 5) a letter and educational materials sent to the primary care provider.
Standard Care
Participants in the standard care arm (brief advice and referral to quit line), will be referred to the MA Quitline which provides free NRT by the study team and will receive an educational brochure related to lung cancer screening.
Locations (2)
Brigham and Women's Hospital
Boston, Massachusetts, United States
Dana Farber Cancer Institute
Boston, Massachusetts, United States